AZNVSBIAF• 28 Days (Normalized)
AZN vs BIAF (AstraZeneca PLC vs bioAffinity Technologies Inc.)
Showing Closing Date Range from Aug, 18 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AZN Performance $161.85
+1.09%
AstraZeneca PLC
Normalized Baseline0.00%
BIAF Performance $6.36
-10.36%
bioAffinity Technologies Inc.
Normalized Baseline0.00%
Alpha Spread Margin AZN LEADS
+11.45%
AZN outperforming by 11.45%
AZNBIAF
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AZN BIAF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | AZN Price | AZN Gain (%) | BIAF Price | BIAF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $161.85 | +1.09% | $6.36 | -10.36% | +11.45% |
| Sep 14, 2026 | $163.78 | +2.30% | $7.93 | +11.77% | -9.47% |
| Sep 11, 2026 | $160.17 | +0.04% | $7.95 | +12.05% | -12.01% |
| Sep 10, 2026 | $159.64 | -0.29% | $9.39 | +32.35% | -32.64% |
| Sep 09, 2026 | $156.94 | -1.97% | $10.50 | +47.99% | -49.96% |
| Sep 08, 2026 | $160.04 | -0.04% | $8.93 | +25.86% | -25.90% |
| Sep 04, 2026 | $162.70 | +1.62% | $15.27 | +115.22% | -113.60% |
| Sep 03, 2026 | $164.77 | +2.92% | $12.78 | +80.13% | -77.21% |
| Sep 02, 2026 | $161.63 | +0.96% | $9.75 | +37.42% | -36.46% |
| Sep 01, 2026 | $162.47 | +1.48% | $6.59 | -7.12% | +8.60% |
| Aug 31, 2026 | $162.13 | +1.27% | $4.56 | -35.73% | +37.00% |
| Aug 28, 2026 | $162.70 | +1.62% | $4.87 | -31.36% | +32.98% |
| Aug 27, 2026 | $164.52 | +2.76% | $5.06 | -28.68% | +31.44% |
| Aug 26, 2026 | $166.27 | +3.85% | $5.09 | -28.26% | +32.11% |
| Aug 25, 2026 | $169.66 | +5.97% | $5.19 | -26.85% | +32.82% |
Page 1 of 2